| The fatty acid–bile acid conjugate aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease R Safadi, FM Konikoff, M Mahamid, S Zelber-Sagi, M Halpern, T Gilat, ... Clinical Gastroenterology and Hepatology 12 (12), 2085-2091. e1, 2014 | 332 | 2014 |
| Randomized comparison of 3 high-level disinfection and sterilization procedures for duodenoscopes GM Snyder, SB Wright, A Smithey, M Mizrahi, M Sheppard, EB Hirsch, ... Gastroenterology 153 (4), 1018-1025, 2017 | 109 | 2017 |
| Comparison of adenoma detection and miss rates between a novel balloon colonoscope and standard colonoscopy: a randomized tandem study Z Halpern, SA Gross, IM Gralnek, B Shpak, M Pochapin, A Hoffman, ... Endoscopy 10 (03), 238-244, 2015 | 101 | 2015 |
| Drug induced liver injury: review with a focus on genetic factors, tissue diagnosis, and treatment options T Khoury, AA Rmeileh, L Yosha, AA Benson, S Daher, M Mizrahi Journal of clinical and translational hepatology 3 (2), 99, 2015 | 94 | 2015 |
| Adalimumab-induced autoimmune hepatitis T Adar, M Mizrahi, O Pappo, A Scheiman-Elazary, O Shibolet Journal of clinical gastroenterology 44 (1), e20-e22, 2010 | 91 | 2010 |
| Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin … M Mizrahi, Y Shabat, A Ben Ya’acov, G Lalazar, T Adar, V Wong, B Muller, ... Journal of inflammation research, 141-150, 2012 | 83 | 2012 |
| Oral administration of OKT3 MAb to patients with NASH, promotes regulatory T-cell induction, and alleviates insulin resistance: results of a phase IIa blinded placebo … G Lalazar, M Mizrahi, I Turgeman, T Adar, A Ben Ya’acov, Y Shabat, ... Journal of clinical immunology 35, 399-407, 2015 | 82 | 2015 |
| The complex role of anticoagulation in cirrhosis: an updated review of where we are and where we are going T Khoury, AR Ayman, J Cohen, S Daher, C Shmuel, M Mizrahi Digestion 93 (2), 149-159, 2016 | 80 | 2016 |
| PEG insertion in patients with dementia does not improve nutritional status and has worse outcomes as compared with PEG insertion for other indications AR Ayman, T Khoury, J Cohen, S Chen, S Yaari, S Daher, AA Benson, ... Journal of clinical gastroenterology 51 (5), 417-420, 2017 | 79 | 2017 |
| The clinical implications of fatty pancreas: a concise review T Khoury, AW Asombang, TM Berzin, J Cohen, DK Pleskow, M Mizrahi Digestive diseases and sciences 62, 2658-2667, 2017 | 71 | 2017 |
| Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells T Adar, A Ben Ya'acov, G Lalazar, Y Lichtenstein, D Nahman, M Mizrahi, ... Clinical & Experimental Immunology 167 (2), 252-260, 2012 | 67 | 2012 |
| The gut mucosa as a site for induction of regulatory T-cells M Mizrahi, Y Ilan Current pharmaceutical design 15 (11), 1191-1202, 2009 | 57 | 2009 |
| G-EYE colonoscopy is superior to standard colonoscopy for increasing adenoma detection rate: an international randomized controlled trial (with videos) H Shirin, B Shpak, J Epshtein, JG Karstensen, A Hoffman, R de Ridder, ... Gastrointestinal endoscopy 89 (3), 545-553, 2019 | 54 | 2019 |
| Endotipsitis‐persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management M Mizrahi, T Adar, D Shouval, AI Bloom, O Shibolet Liver International 30 (2), 175-183, 2010 | 47 | 2010 |
| Gastric stimulation for weight loss M Mizrahi, AB Ya'acov, Y Ilan World journal of gastroenterology: WJG 18 (19), 2309, 2012 | 40 | 2012 |
| Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients M Mizrahi, G Lalazar, T Adar, I Raz, Y Ilan Nutrition journal 9, 1-9, 2010 | 40 | 2010 |
| β-Glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination M Mizrahi, G Lalazar, AB Ya’acov, DM Livovsky, Y Horowitz, L Zolotarov, ... Vaccine 26 (21), 2589-2595, 2008 | 40 | 2008 |
| Full-thickness resection device (FTRD) for treatment of upper gastrointestinal tract lesions: the first international experience K Hajifathalian, Y Ichkhanian, Q Dawod, A Meining, A Schmidt, N Glaser, ... Endoscopy international open 8 (10), E1291-E1301, 2020 | 38 | 2020 |
| Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation RT Stravitz, A Reuben, M Mizrahi, G Lalazar, K Brown, SC Gordon, Y Ilan, ... Journal of hepatology 63 (6), 1345-1351, 2015 | 33 | 2015 |
| Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma GK Patel, JA Laurini, A Bhardwaj, K Roveda, R Donnell, K Sherling, ... Journal of gastrointestinal oncology 10 (4), 695, 2019 | 29 | 2019 |
